Data / Form D filings / TRANSLUMINAL TECHNOLOGIES LLC
TRANSLUMINAL TECHNOLOGIES LLC: Form D filings
TRANSLUMINAL TECHNOLOGIES LLC, a biotechnology company in Syracuse, NY, filed 3 Form D notices with the SEC between 2014 and 2020. The latest, on April 21, 2020, reports $1.5 million sold of a $1.5 million offering to 27 investors.
Find out what TRANSLUMINAL TECHNOLOGIES LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2930 E. Genesee St., Syracuse, NY, 13224
- Phone
- (315) 476-7510
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- New York
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1433106
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 21, 2020 | New notice | $1,500,000 | $1,500,000 | $0 | 27 | Aug 23, 2011 | sec.gov |
| May 20, 2015 | Amendment | $1,500,004 | $1,500,004 | $0 | 32 | Jul 18, 2013 | sec.gov |
| Jan 27, 2014 | New notice | $1,500,004 | $315,254 | $1,184,750 | 5 | Jul 18, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen M Green | Executive Officer, Director | |
| Mikio M Miyawaki | Director | |
| Ronald M Caputo | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Apr 20, 2020 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TRANSLUMINAL TECHNOLOGIES LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.